page_banner

Products

tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridinum-3-yl) piperazinum-1-carboxylatum CAS: 866084-31-3

Description:

Catalogue Number: XD93402
Cas: 866084-31-3
Formulae hypotheticae: C33H45N7O4
Pondus hypotheticum: 603.75
Availability: In Stock
Pretium:  
Prepack:  
Mole Pack: Request Quote

 


Product Detail

Product Tags

Catalogue Number XD93402
Product Name tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridin-3-yl) piperazine-1-carboxylate
CAS 866084-31-3
Formulae hypotheticaela C33H45N7O4
M. Pondus 603.75
Repono Details Ambiens

 

Product Specification

Aspectus Pulvis albus
Assay 99% min

 

Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridin-3-yl) piperazinum-1-carboxylatum est compositum cum immensa potentia in chemia medicinali et medicamento evolutionis.Eius multiplex structura hypothetica varias applicationes potentiarum suggerit. Haec compositio nucleum piperazinum-1-carboxylatum continet, quod vulgo catasta in chemia medicinali adhibetur, propter variabilem indolem et amplis machinis medicamentorum facultatum.Praesentia medietatis piperazinae permittit pro commercio cum variis receptoribus et enzymis, ut candidatum interesting evolutionis agentium medicinalium efficiat. The 6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7; 8-dihydropyrido[2,3-d] pyrimidin-2-y globus in structura potentialem actionem pharmacologicam praebet.Tales derivationes pyridi[2,3-d] pyrimidines late quaesitae sunt pro proprietatibus anti-inflammatoriis, antiviralibus et anticanicis.Circulus cyclopentylus et methyl conferunt ad lipophilicitatem compositi, quae eius cellulosam permeabilitatem et bioavailbilitatem augere potest. Tert-butyl ester coetus stabilitatem praebet compositi et facile ad alios coetus functiones converti potest, permittens ulteriores modificationes vel derivationes.Haec flexibilitas in chemiae medicinali valet, ut evolutionem potentiorum et selectorum compositorum dat. Pyridin-3-yl coetus in structura agit ligandi potentiale pro variis receptoribus, ut G interdum-coniunctis receptoribus (GPCRs).Hoc suggerit compositum ut ictum habere possit in vias intracellulares significantes, et ulterius explorari pro sua potentia ut modulator vel adversario receptorum specificorum in morbis conditionibus implicatorum. Altiore structura tert-butyl 4-(6-((6- (1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridinum-3-yl)piperazinum-1-carboxylatum elucidat ejus potentia in evolutione novarum medicinalium.Occasiones praebet explorandi enzyme inhibitionis, receptoris ligaturae et modulationis varios processus biologicos. Cum ulteriore exploratione et optimizatione, haec compositio plumbeis mixtis potentia inservire potest ad progressionem medicamentorum cancer, inflammationis, vel aliorum morborum.Eius singulares notae structurales et actiones biologicae potentiae interesting componunt ad ulteriorem inquisitionem et progressionem in agro chemiae medicinalis. In conclusione, tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl- 5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridin-3-yl) piperazinum 1-carboxylatum pollicetur ut compositio versatilis ad medicamentorum evolutionem.Eius multiplex structura et potentia pharmacologicae operationes efficiunt candidatum ambientem ad ulteriorem inquisitionem sicut potentialem agens therapeuticum pro variis morbis et condicionibus.


  • Priora:
  • Deinde:

  • Close

    tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridinum-3-yl) piperazinum-1-carboxylatum CAS: 866084-31-3